PERSONAL INFORMATION
Name: Jianghong Yan
Gender: Female
Title: Associate professor
CONTACT INFORMATION
Email: yanjianghong@cqmu.edu.cn
Address: Institute of Life Sciences, Chongqing Medical University, Chongqing 400010, China
Phone: +86-023-63664754
EDUCATION EXPERIENCE
2005.9-2013.6 Biochemistry and molecular biology, Institute of microbiology, University of Chinese Academy of Sciences, PhD.
2001.9-2005.6 Biological sciences, Huazhong Normal University, Bachelor's degree.
WORKING EXPERIENCE
2021.11- Institute of Life Sciences, Chongqing Medical University, Associate professor
2020.10- Institute of Life Sciences, Chongqing Medical University, Associate researcher
2013.07-2020.09，Institute of Life Sciences, Chongqing Medical University, Research assistant.
RESEARCH INTERESTS
Cardiovascular pharmacology; Tumor pharmacology.
PUBLICATIONS
1) Dingyi Lv#, Minghao Luo#, Zhe Cheng, Ruiyu Wang, Xiyang Yang, Yongzheng Guo, Longxiang Huang, Xiang Li, Bi Huang, Jian Shen, Suxin Luo, Jianghong Yan*, Tubeimoside I Ameliorates Myocardial Ischemia-Reperfusion Injury through SIRT3-Dependent Regulation of Oxidative Stress and Apoptosis, Oxidative Medicine and Cellular Longevity, 2021, 2021: 5577019
2) Xiyang Yang#, Xingbing Li, Minghao Luo, Chang Li, Longxiang Huang, Xiang Li, Bi Huang, Jiang Shen, Suxin Luo*, Jianghong Yan*, Tubeimoside I improves endothelial function in sepsis via activation of SIRT3, Laboratory Investigation, 2021, 101(7):897-907.
3) Xiyang Yang#, Xingbing Li#, Minghao Luo, Yongzheng Guo, Chang Li, Dingyi Lv, Zhe Cheng, Longxiang Huang, Fei-Fei Shang, Bi Huang, Jian Shen, Suxin Luo*, Jianghong Yan*, Tubeimoside I promotes angiogenesis via activation of eNOS-VEGF signaling pathway, Journal of Ethnopharmacology, 2021, 267: 113642
4) Minghao Luo#, Suxin Luo, Zhe Cheng, Xiyang Yang, Dingyi Lv, Xingbing Li, Yongzheng Guo, Chang Li, Jianghong Yan*, Tubeimoside I improves survival of mice in sepsis by inhibiting inducible nitric oxide synthase expression, Biomedicine & Pharmacotherapy, 2020, 126:110083.
5) Jianghong Yan#，Xiaoyun Dou, Jing Zhou, Yuanfeng Xiong, Ling Mo, Longhao Li*, Yunlong Lei*, Tubeimoside I sensitizes colorectal cancer cells to chemotherapy by inducing ROS-mediated impaired autophagolysosomes accumulation, Journal of Experimental ＆ Clinical Cancer Research, 2019, 38: 353.
